Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination supplement composed of **coenzyme Q10, omega-3 fatty acids**, and **resveratrol**, this formulation is designed to leverage the antioxidant, anti-inflammatory, and cardioprotective properties of each component. **Coenzyme Q10** is a mitochondrial cofactor essential for ATP production and acts as an antioxidant. **Omega-3 fatty acids** (primarily EPA and DHA) are long-chain polyunsaturated fatty acids known for their cardiovascular benefits, anti-inflammatory effects, and positive influence on lipid metabolism. **Resveratrol** is a polyphenol with antioxidant, anti-inflammatory, and signaling pathway modulating effects, investigated for cardiometabolic, neuroprotective, and anticancer applications. The combination has shown synergistic effects in reducing inflammation and oxidative stress, improving mitochondrial function, and stabilizing fatty acids against oxidative degradation. There is preclinical and early clinical evidence for the benefit of combined supplementation in diseases characterized by chronic inflammation and oxidative stress, including but not limited to arthritis, cardiovascular disease, and metabolic dysfunction[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coenzyme Q10 + omega-3 fatty acids + resveratrol.